Sangamo Therapeutics Inc SGMO Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	617.13M	593.91M	562.51M	440.57M	325.07M	219.7M	165.32M	128.96M
Total Current Assets	343.12M	336.62M	300.33M	227.09M	159.61M	147.58M	94.33M	68.64M
Cash and Equivalents	117.71M	94.57M	100.44M	78.24M	66.83M	56.51M	45.2M	54.42M
Total Non-Current Assets	274.01M	257.29M	325.71M	213.48M	165.47M	72.12M	97.87M	60.33M
Total Liabilities	298.85M	284.76M	267.55M	104.96M	91.43M	84.78M	82.43M	72.26M
Total Current Liabilities	119.99M	122.36M	111.71M	57.84M	53.79M	48.48M	47.73M	40.24M
Total Non-Current Liabilities	178.86M	162.4M	155.84M	47.12M	37.64M	36.29M	34.7M	32.02M
Common Equity	1.53M	1.62M	1.67M	1.72M	1.77M	1.77M	1.78M	2.04M
Retained Earnings	-1.04B	-1.1B	-1.15B	-1.13B	-1.24B	-1.35B	-1.41B	-1.46B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	157.89M	286.74M	590.4M	637.52M	938.55M	721.92M	562.51M	165.32M
Total Current Assets	149.58M	248.4M	410.52M	405.47M	659.67M	398.77M	300.33M	94.33M
Cash and Equivalents	22.06M	49.83M	140.42M	80.43M	131.33M	178.87M	100.44M	45.2M
Total Non-Current Assets	136.2M	187.9M	367.26M	432.74M	497.37M	375.34M	294.96M	82.89M
Total Liabilities	21.7M	98.84M	223.14M	204.78M	441.18M	346.58M	267.55M	82.43M
Total Current Liabilities	13.29M	44.86M	78.51M	69.87M	143.55M	127.89M	111.71M	47.73M
Total Non-Current Liabilities	12.35M	78.72M	172.32M	134.91M	297.64M	218.69M	155.84M	34.7M
Total Equity	136.2M	187.9M	367.26M	432.74M	497.37M	375.34M	294.96M	82.89M
Common Equity	709k	856k	1.02M	1.16M	1.42M	1.46M	1.67M	1.78M
Retained Earnings	-440.91M	-495.48M	-562.7M	-656.99M	-777.98M	-956.27M	-1.15B	-1.41B